Subacute sclerosing panencephalitis
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
neurological disorder |
| gptkbp:abbreviation |
gptkb:SSPE
|
| gptkbp:affects |
central nervous system
|
| gptkbp:affectsMostly |
children
young adults |
| gptkbp:causedBy |
persistent infection with measles virus
|
| gptkbp:diagnosedBy |
gptkb:EEG
MRI CSF analysis measles antibody titers |
| gptkbp:firstDescribed |
1933
|
| gptkbp:frequency |
rare
|
| https://www.w3.org/2000/01/rdf-schema#label |
Subacute sclerosing panencephalitis
|
| gptkbp:ICD-10_code |
A81.1
|
| gptkbp:mortalityRate |
high
|
| gptkbp:onset |
years after measles infection
|
| gptkbp:prevention |
measles vaccination
|
| gptkbp:prognosis |
poor
|
| gptkbp:symptom |
behavioral changes
seizures motor dysfunction myoclonus visual disturbances progressive intellectual deterioration |
| gptkbp:treatment |
antiviral drugs
immunomodulatory therapy |
| gptkbp:bfsParent |
gptkb:Measles_virus
|
| gptkbp:bfsLayer |
6
|